The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.EBI
University Of Copenhagen
Synthesis and studies on the mGluR agonist activity of FAP4 stereoisomers.EBI
Univ. Rouen
Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).EBI
Vanderbilt University Medical Center
Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence.EBI
Sanford-Burnham Medical Research Institute
A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.EBI
Universite Paris Descartes
(S)-homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors.EBI
Royal Danish School Of Pharmacy
Metabotropic glutamate receptors: novel targets for drug development.EBI
Cns Research
Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkinEBI
Vanderbilt University Medical Center
Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.EBI
Banyu Tsukuba Research Institute
L-(+)-2-Amino-4-thiophosphonobutyric acid (L-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency.EBI
Université
Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.EBI
Faust Pharmaceuticals
Development and profiling of mGluEBI
Vanderbilt University
Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists.EBI
Taisho Pharmaceutical
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.EBI
Eli Lilly
Synthesis and SAR of a series of mGluEBI
Vanderbilt University
Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGluEBI
Vanderbilt University
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGluEBI
Vanderbilt University School Of Medicine
Surveying heterocycles as amide bioisosteres within a series of mGluEBI
Vanderbilt University
Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGluEBI
Vanderbilt University School Of Medicine
Discovery of VU6005649, a CNS Penetrant mGluEBI
Vanderbilt University
VU6010608, a Novel mGluEBI
Vanderbilt University